BIS icon

ProShares UltraShort NASDAQ Biotechnology
BIS

Overview Fund Trends Analyst Outlook Journalist POV

10 hedge funds and large institutions have $3.17M invested in ProShares UltraShort NASDAQ Biotechnology in 2021 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more first-time investments, than exits

New positions opened: | Existing positions closed:

more ownership

Funds ownership: →

more funds holding

Funds holding: →

75% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 4

Holders
10
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$1.06M
2
+$1.03M
3
+$256K
4
IMC Chicago
IMC Chicago
Illinois
+$42.3K
5
CG
Cutler Group
California
+$2K

Top Sellers

1
-$376K
2
-$54K
3
-$45.1K
4
Simplex Trading
Simplex Trading
Illinois
-$21K
5
Osaic Holdings
Osaic Holdings
Arizona
-$15K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$1.06M
2
$1.03M
3
$362K
4
$304K
5
$256K
6
$153K
7
$2K
8
$2K
9
$2K
10
–
11
–
12
–